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M.J. Bown,* M.G.A. Norwood and R.D. SayersDepartment of Surgery, Leicester Royal Infirmary, University of Leicester, Robert Kilpatrick Clinical Sciences
Building, Leicester LE2 7LX, UKIntroduction. Patients with concurrent renal impairment and abdominal aortic aneurysms present a significant challenge
in terms of pre-operative, intra-operative and post-operative management. This aim of this review was to determine the risks
of surgery in this patient group and determine whether any clear management strategies exist to enhance their clinical
management.
Methods. Systematic review of published literature giving details of the outcome of open or endovascular abdominal aortic
aneurysm repair in patients with pre-operative renal impairment. Papers concerning the management of post-operative
acute renal failure in patients with normal pre-operative renal function has not been included.
Results. There is little data regarding patients with end-stage renal failure and AAA although these patients appear to have
a high peri-operative mortality rate. In contrast, those with renal impairment do not have a significantly higher mortality
rate than those with normal renal function, rather they have a higher risk of complications associated with surgery and may
require more intensive post-operative organ system support than normal patients. Many have a transient deterioration in
renal function in the immediate peri-operative period that will resolve. In the case of patients with ruptured AAA, it is not
clear whether pre-operative renal impairment affects mortality.Keywords: Abdominal aortic aneurysm; Renal failure.Introduction
Both open and endovascular abdominal aortic aneur-
ysm (AAA) repair is associated with a significant risk
of mortality and morbidity.1,2 In the presence of
additional co-morbid conditions these risks may be
much increased. In some cases, aneurysmal disease
may be accompanied by concurrent renal impairment.
It is widely perceived that pre-operative renal
impairment will lead to an increased risk of post-
operative acute renal failure. Acute renal failure has a
high mortality rate, with estimates between 50 and
80% in patients developing acute renal failure from
any causes.3–5 Following AAA repair the mortality
from acute renal failure is similar at 60–90%.6,7 In those
patients, who survive an episode of post-operative
renal failure after AAA repair there is a small risk ofing author. M.J. Bown, MD, MRCS, Department of
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is associated with a poor long-term prognosis.
Because of the high risk of post-operative acute
renal failure, the management of AAA patients with
pre-operative renal impairment is not straightforward.
Firstly, the decision on whether to proceed to operative
intervention may be influenced by their increased
operative risk. Secondly, the surgical approach—open
or endovascular—has to be determined in the light of
renal impairment and, finally, a strategy to minimise
the risk of surgery by optimising peri-operative renal
function has to be instituted. Surgery in these patients
may also be complicated by the increased incidence of
ischaemic heart disease, atherosclerotic calcification
making surgery technically more complicated, and
coagulopathy due to uraemia associated platelet
dysfunction.
Unfortunately, there is a lack of published literature
concerning the management of this select group of
patients. This paper aims to review the current
literature regarding the risks of AAA repair in patientsEur J Vasc Endovasc Surg 30, 1–11 (2005)
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ment of such cases. The effects of AAA repair on renal
function and strategies to preserve renal function
during AAA repair are presented. Reviews of the
operative approaches to anomalous renal tract anat-
omy and heterotopic renal transplants have been
excluded.Methods
A systematic review of the published English
language literature was performed to identify studies
potentially relevant to the topic. Searches of the
MEDLINE (January 1966 to December 2003) and
EMBASE (January 1980 to December 2003) electronic
databases was performed using the Ovid (version
9.1.0) search engine. The following search strategy was
used on both databases: [‘aortic aneurysm, abdominal’
(keyword) OR ‘abdominal aortic aneurysm’ (text-
word)] AND [‘renal failure’ (textword) OR ‘kidney
failure’ (keyword)]. In addition, manual searching of
reference lists from articles retrieved by electronic
searching was used to identify those articles published
prior to the inception of these databases and for any
missed by the electronic searches. Where articles
included data from other systematic reviews authors
were contacted directly to obtain information on the
articles examined in those reviews.9 Articles retrieved
were restricted to those published in English. All types
of study were included. Only those articles that
described the outcome of patients with renal impair-
ment, those detailing the effects of AAA repair on
renal physiology and those describing strategies to
reduce the renal injury caused by AAA repair were
included in the study. Articles concerning post-
operative renal failure in patients without pre-existing
renal disease were excluded.
Electronic searching identified 514 potential articles
for inclusion in the analysis. Three hundred and
eighty-one of these were rejected for the reasons
outlined above based on the examination of electro-
nically available abstracts (the majority of these
concerned post-operative renal failure in patients
with no pre-existing renal impairment). The remaining
133 articles were obtained either from local library
collections, the British Medical Association Library or
the British Library. Where no electronic abstract was
available for examination the full article was retrieved.
Of these articles only 66 were directly relevant to this
study. A further eight relevant articles were identified
by manual searching of those articles retrieved.
All measures of serum creatinine have been quoted
in mmol/l. Where articles gave figures in mg/dl theseEur J Vasc Endovasc Surg Vol 30, July 2005were converted into mmol/l. For the purposes of this
review the term ‘renal impairment’ was used to
classify those patients with abnormal renal function
but who were not dialysis dependent. The term ‘end-
stage renal failure’ was reserved for those patients
who were dependent on dialysis. The criteria used to
define the study groups in each article retrieved are
shown in Table 1.Outcome of Elective AAA Repair in Patients with
Abnormal Renal Function: MortalityEnd-stage renal failure
There is very little published data regarding AAA
repair in patients with end-stage renal failure. Cohen
et al.10 describe a series of four patients who were
operated upon electively and in this group there was
one death before discharge from hospital (25%).
Norwood et al.11 describe a similar group of five
patients of whom three died (60%). No published data
exists for the outcome of ruptured AAA repair in
patients with end-stage renal failure. Clearly, these
small series make statistical estimation of the true
population mortality rate impossible but it is clearly
far in excess of that for patients with normal renal
function.Renal impairment
In patients with renal impairment reported mortality
rates vary but few authors report figures markedly
higher than in patients without renal impairment.
Comparison between studies is not straightforward
since the criteria used to define renal impairment vary
between studies. In 50 patients with a mean creatinine
of 256 mmol/l (standard error 35), including three
patients receiving chronic haemodialysis Komori et
al.12 demonstrated a mortality rate of 2% (one patient).
All patients in this study group had a serum creatinine
greater than 177 mmol/l. Sugawara et al.,13 reported on
a similar population of patients (nZ33) with a mean
serum creatinine of 221 mmol/l (standard deviation
150) and found a mortality rate of 9.1% (three
patients). This included four patients receiving chronic
haemodialysis and all patients had creatinine levels
greater than 133 mmol/l. Neither of these two studies
gave details of the cause of death in those patients
who died. It should be noted that, in these two studies
even if all the deaths occurred in the patients on
chronic haemodialysis, the mortality rates for the
Table 1. Outcome of AAA repair in patients with renal impairment/end-stage renal failure
Study Open/
EVAR
Ruptured/
elective
n Selection
criteria
(mmol/l)
Creatinine (mmol/l) Variability Mortality
Mean Median n %
Cohen10 Open Elective 4 ESRF 1 25
Norwood11 Open Elective 5 ESRF 3 60
Komori12 Open Elective 50 O177* 256 SEM 35 1 2
Suga-
wara13
Open Elective 33 O133* 221 SD 150 3 9.1
Cohen10 Open Elective 16 O177 0 0
Norwood11 Open Elective 7 O177 1 14.3
Jordan70 Open Elective 10 O176 1 10
Jordan70 EVAR Elective 13 O176 0 0
Chuter71 EVAR Elective 13 O133 0 0
Walker72 EVAR Elective 15 O130* 227 IQR 137 to
514
4 27
* Some patients with end-stage renal failure included in study group. ESRF, end-stage renal failure; EVAR, endovascular AAA repair; SEM,
standard error of the mean; SD, standard deviation; IQR, inter-quartile range.
AAA and Renal Failure 3haemodialysis patients are similar to the studies by
Norwood and Cohen described above.10,11
Other, smaller descriptive studies have reported
variable mortality outcomes in these patients varying
from010 to 14.3%.11 In one study identified, themortality
rate was not stated.14 Few comparative studies were
identified. The largest study found, by Heller et al.,15
examined 358,521 patients admitted to North American
hospitals for elective AAA repair over a 19 year period.
Using the ICD-9 code to define renal failure (a
descriptive definition with no strict cut-off point in
terms of serum creatinine value) no effect on mortality
was found. One much smaller but more detailed report
from a single centre found that in patients with
suprarenal AAA there was no difference in mortality
between those with pre-operative renal impairment
(creatinine greater than 123 mmol/l, nZ14) compared
with thosepatientswithnormal renal function (nZ98).16
A singlemeta-analysis that gave details of the effect of
pre-operative renal impairment on mortality was ident-
ified.9 This used a random-effectsmodel to pool the data
from four previous studies that had examined the
consequence of pre-operative renal impairment (despite
obtaining a copyof the references from the authors itwas
not possible to identify the actual articles). In these four
pooled studies (a total of 10,174 patients) the relative risk
estimate for post-operative mortality in patients with
pre-operative renal impairment (undefined) was from
4.2 to 9.0. (The authors do not state whether this was a
95% confidence interval for a pooled estimate but it
seems it may merely be the range of the relative risk
found in each individual study.) This finding is clearly in
contrast to those studies reported above and notably did
not include the large study by Heller et al. which
demonstrated no relationship between pre-operative
renal impairment and mortality.15Outcome of Elective AAA Repair in Patients with
Abnormal Renal Function: Morbidity
Whilst the mortality estimates associated with pre-
operative renal impairment vary it does appear to be
associated with a significant degree of morbidity,
including an increased risk of developing dependence
on haemodialysis (or other forms of renal replacement
therapy). Sugawara et al.13 found a significant increase
in morbidity in 33 patients with pre-operative creati-
nine levels greater than 177 mmol/l when compared to
217 patients with normal renal function (undefined
morbidity rates 30.3 vs 12.9%, PZ0.0095). One of the
patients in the group with pre-operative renal impair-
ment went on to become dialysis dependent. Two
small studies have identified a relatively high rate of
end-stage renal failure complicating AAA repair in
these patients, with rates between 33 and 71%.10,11 In a
selected group of patients, all with chronic respiratory
disease, Upchurch et al.17 found that in those 25 who
developed complications (myocardial infarction, acute
renal failure or requirement for prolonged respiratory
support) pre-operative creatinine levels were signifi-
cantly higher than in the 133 without complications
(193.6 vs 114.4 mmol/l, PZ0.006) and after multi-
variate analysis pre-operative renal impairment was
an independent predictor of morbidity.Outcome of Elective AAA Repair in Patients with
Abnormal Renal Function: Long Term Outcome
In limited numbers of studies (2), where long-term
outcome has been studied this appears to be signifi-
cantly reduced in patients with pre-operative renal
impairment. In these two studies, the 5-year survivalEur J Vasc Endovasc Surg Vol 30, July 2005
M. J. Bown et al.4rates found were 43.512 and 60%,13 compared to
figures of 78.1 and 84% for patients without renal
impairment from the same study groups. Also
reported in these studies is the 5 year survival in
patients with renal impairment who were not oper-
ated upon K20%.12
It is difficult to determine whether there is a true
effect of renal failure on mortality after elective AAA
repair, largely due to differences in the criteria used to
define renal failure and small numbers in each study.
There is, however, a clear increase in the incidence of
morbidity in these patients, including worsening of
renal function and a risk of developing end-stage renal
failure and the requirement for dialysis together with a
reduced long-term survival rate. These findings are
summarised in Table 1.Outcome of Ruptured AAA Repair in Patients with
Abnormal Renal Function: Mortality
No reports exist of ruptured AAA repair in patients
with end-stage renal failure. In the meta-analysis
described above9 the results for the effect of renal
impairment on outcome were not as marked. One
study demonstrated a positive association between
renal failure (undefined) and mortality (147 patients,
relative risk estimate 2.3), six studies showing no
association (1921 patients, no relative risk estimates
stated). In our own work, we have found no
association between pre-operative renal impairment
and mortality after ruptured AAA repair in a multi-
variate analysis (139 patients).18 Whilst other authors
have demonstrated associations between pre-operat-
ive creatinine levels and mortality in univariate
analyses none of these show an association when
subjected to multi-variate analysis.19–22 Except for that
by Johnston et al.23 where pre-operative creatinine
greater than 114 mmol/l was an independent predictor
of mortality in 147 patients undergoing ruptured AAA
repair. Heller et al.15 found a higher mortality in those
with pre-operative renal impairment compared to those
without (as defined by ICD-9 code). Mortality in
those with renal impairment was 68.7% compared to
42.8% in those without renal impairment, odds ratio 2.5
(95%confidence interval 1.3–4.9, 67,751patients in total).
The most significant confounding factor in inter-
preting the above results is the method of defining
renal impairment. In the above studies it is not clear
whether the definitions of renal impairment were
made immediately pre-operatively or based on
chronic impairment. It may be that in some cases the
effects of rupture itself precipitated acute deterioration
in renal function. This would result in patients with noEur J Vasc Endovasc Surg Vol 30, July 2005chronic renal impairment being incorrectly classified as
having renal impairment and confounding the results.
One study identified had reported the incidence of
renal failure in patients with and without pre-
operative renal impairment but had grouped both
elective and emergency procedures in the same out-
come group making meaningful interpretation
impossible.24Peri-operative Management
Little data and evidence exists for the optimal methods
to prepare patientswith pre-operative renal impairment
for surgery. In the case of the patients presenting with
rupture there is little opportunity for pre-operative care.
In these cases, the decision to operatemay be influenced
by the presence of renal impairment.
In the patients presenting non-acutely more time is
available to identify and treat risk factors for surgery. It
has been suggested that investigations to identify renal
artery stenosis and the maintenance of adequate
intravenous hydration pre-operatively are the only
useful strategies.25 However, in the majority of centres
basic investigations in the form of serum urea and
electrolyte measurement will be performed identify
patients with renal impairment. Those identified to
have renal impairment would then undergo renal
ultrasound to determine renal size and identify any
potentially reversible cause for their renal impairment
such as obstructive nephropathy. These investigations
may include renal artery Doppler studies to detect
renal artery stenosis. Microbiological analysis of a
mid-stream urine specimen should be performed to
detect occult infection. Functional renal investigations
are rarely performed although pre-operative CT
scanning may provide an opportunity to identify
functional data on renal perfusion.26 In the majority of
patients with renal impairment the only correctable
contributing factors will be nephrotoxic drugs (e.g.
non-steroidal anti-inflammatory agents, angiotensin
converting enzyme inhibitors), renal artery stenosis or
obstruction including that due to inflammatory AAA
or prostatic hypertrophy. Nephrotoxic drugs can be
stopped with relative ease but the treatment of renal
artery stenosis may complicate AAA repair in terms of
method and timing. Adequate pre-operative
hydration should be ensured.Renal Artery Stenosis
In many patients with renal impairment there is not a
readily reversible cause for their disease. However, in
AAA and Renal Failure 5some patients renal impairment may be due to renal
artery stenosis. This usually affects both renal arteries if
it is severe enough to be detectable by serum biochem-
istry analysis. Since, AAA and atherosclerosis share
similar risk factors and aetiological processes it is likely
that in patients with renal impairment and AAA a
significant proportion may have renal impairment due
to atherosclerotic renal artery stenosis. This raises the
possibility of treating patients with renal artery stenosis
pre-operatively and thus improving their renal function.
Unfortunately, the detection of renal artery stenosis
requires either invasive orcomplex radiological imaging
whichmay not be available in all vascular surgical units.
If renal artery stenosis is detected, it may be treated by
angioplasty prior to proceeding with AAA repair,
however, there is the alternative possibility of treating
both theAAAand the renal artery stenosis concurrently.
Recent series have demonstrated that renal artery
endarterectomy, either unilateral or bilateral can be
feasibly combined with aortic surgery27 and significant
short-term improvements in renal function can be
achieved28 with little apparent effect on mortality.29
Ballard et al.30 reported on a comparative study between
32patients treatedwith either pre-operative angioplasty
or simultaneous open reconstruction/endarterectomy.
In the 18 patients treated with angioplasty, four failed
andhad tobesubsequently treatedat the timeof surgery.
There was no difference in long- or short-term outcome
in either groupwith 67%of patients having improvedor
no change in renal function. Whether the analysis was
based on an intention to treat basis was not stated.
Similar figures for long-term improvement in renal
functionhave also beendemonstrated in other studies.31
The only study to compare mortality has shown no
difference between patients undergoing juxta/supra-
renal AAA repair with or without concurrent renal
artery reconstruction (30 vs 35patients).32One studyhas
identified that patients undergoing simultaneous renal
artery reconstruction with aortic surgery may be at
increased risk of developing end-stage renal failure.13
However, this study only examined five patients under-
going renal artery reconstruction, all of whom had a
significant degree of renal impairment (mean creatinine
265 mmol/l (standard deviation 177)) and compared
them with 21 patients (mean creatinine 159 mmol/l
(standard deviation 44)) who did not have renal artery
reconstruction.Intra-operative Strategies to Preserve Renal
Function
Inorder toexaminepotential intra-operative therapeutic
strategies to preserve renal function in patients withrenal impairment it is necessary to understand how
aortic surgery affects renal function. This is clearly
related to the alterations in renal perfusion caused by
cross-clamping the aorta close to or above the origins of
the renal arteries and may be affected by changes in
systemic haemodynamics caused by cross-clamping
distal to the origins of the renal arteries.Renal Haemodynamics During Aortic Surgery
Significant decreases in renal perfusion occur during
infra-renal aortic clamping despite no significant
changes in systemic blood pressure or cardiac out-
put.33 Observed changes include a 75% increase in
renal vascular resistance with an associated 38%
reduction of renal blood flow. In addition, redistribu-
tion of renal blood flow to the cortical areas has been
shown, which is thought to be a protective mechanism,
preserving blood flow to the glomeruli. These
observed changes did not resolve within an hour of
removing the aortic clamp, beyond which no further
measurements were taken. The changes in renal blood
flow and their lack of relationship to cardiac output
and systemic blood pressure have also been observed
in other studies.34 It has been postulated that these
changes are due to activation of the renin–angioten-
sin–aldosterone system, with angiotensin II causing
the increase in renal vascular resistance. These
changes do not appear to cause any significant
deterioration in renal function in patients with normal
pre-operative renal function.33 Pull ter Gunne et al.35
found no change in serum creatinine levels in 21
patients with normal renal function as a result of infra-
renal clamping at either 1 h, 1 day or 1 week after
surgery. However, whilst there may be no change in
function in terms of serum creatinine measurements
Awad et al.36 demonstrated a small but significant
decrease in glomerular filtration rate and renal plasma
flow 6 months after elective infra-renal AAA repair in
the majority of patients. In patients with normal renal
function this slight decrease may be so negligible as to
not cause any significant effect. However, in patients
with impaired renal function who have already lost a
significant degree of functional renal tissue these
changes may be significantly large enough to
adversely affect renal function.
When the aorta is cross-clamped above the origin of
one or both renal arteries there is an additional direct
ischaemia-reperfusion injury to the kidneys in
addition to the changes outlined above that will
occur later during the procedure. It has been suggested
that up to 60 min of warm ischaemia is safe37 but
obviously the minimum length of clamp time isEur J Vasc Endovasc Surg Vol 30, July 2005
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effects of supra-renal cross-clamping on renal function.
Some studies have noted a transient rise in post-
operative serum creatinine in patients with normal
renal function who requires a period of supra-renal
clamping but no effect onmortality rates or the need for
subsequent chronic dialysis.38–40 In all of these studies
serum creatinine levels returned to baseline levels
within 2 weeks of surgery in the patients with
uncomplicated recoveries. The degree of post-operative
renal impairment associated with supra-renal clamping
has been shown tobeproportional to the lengthof clamp
time.41 One article described a deterioration in renal
function (long-term) inpatientswithpre-operative renal
impairment (creatinine greater than 158 mmol/l) in
patients who required supra-renal clamping.42
In addition to the direct ischaemia-reperfusion
injury, caused by supra-renal clamping there is also
the risk of dislodging atheroma from the wall of the
aorta at the site of clamping depending on the degree
of atherosclerosis present. If this is just proximal to the
renal arteries this may cause renal embolism. This
phenomenon was demonstrated by Green et al.43 (52
patients) who found that supra-coeliac clamping was
associated with a lower mortality (3%, one death) than
suprarenal clamping (32% mortality rate, seven
deaths) due to the renal artery embolisation of
dislodged atherosclerotic debris from the juxtarenal
aorta. This was converse to the study by Sarac et al.42
(138 patients) where supra-coeliac clamping (nZ43)
significantly increased the odds of mortality (odds
ratio 6.1 (95% confidence interval 1.1–32.9)). Again, in
contrast to both of these studies, Shortell et al.16 (112
patients) found no significant difference in mortality if
the clamp was placed in either a supra-renal or supra-
coeliac position (92 vs 20 patients).
A further intra-operative technical factor that could
affect renal function is the division of the left renal vein.
Only relatively small series of patients (3–58) with
normal renal function have been reported, with the
majority demonstrating no change in renal function,
either peri-operatively or long-term.44–47Only the largest
series (58patients) has shown any significant effect of left
renal vein ligation which was a rise in serum creatinine
levels in the post-operativeperiodwhich had resolved in
all cases when assessed at 1 week and 1 month.48Strategies to Preserve Renal FunctionSurgical
Given the changes in renal haemodynamics outlinedEur J Vasc Endovasc Surg Vol 30, July 2005above and their effects on renal function it is desirable
to make attempts to reduce the impact of these
changes, especially in patients who have pre-existing
renal impairment. Little can be done to alter the effects
of infra-renal aortic clamping on renal perfusion.
Where a supra-renal or supra-coeliac clamp is utilised
surgical techniques to preserve renal function are
either based on hypothermic perfusion of an ischaemic
kidney or maintaining renal perfusion using bypass
techniques. These have been previously been
described elsewhere. In patients with renal impair-
ment these techniques have been utilised and/or
adapted. Allen et al.32 used hypothermic perfusion of
kidneys (cooled heparinized saline) during supra/
juxta-renal AAA repair in 23 patients with creatinine
levels greater than 158 mmol/l and found no deterio-
ration in serum creatinine levels at discharge from
hospital although these patients did demonstrate a
higher transient post-operative rise in creatinine than
in patients without pre-op renal impairment. Bypass
techniques using grafts from upper limb vessels,
cardio-pulmonary bypass machines or shunts inserted
locally have all been described in these cases.49–51 A
combination of techniques may also be utilised.
AbuRahma et al.52 described a successful case where
an AAA involving the left renal artery was operated
on by performing a nephrectomy, perfusing the kidney
with University of Wisconsin solution (cold) outside of
the abdomen and then re-implanting it into the graft.
The right kidney was perfused in situ. In a case where
severe right renal artery stenosis in a supra-renal AAA
was causing renal impairment Putnam et al.53 per-
formed a near identical procedure.Medical
Pharmacological therapies have been suggested to
maintain renal function in patients with pre-existing
renal impairment although none have been subjected
to rigourous clinical trials. None of these have been
specifically trialed in patients with pre-operative renal
impairment. Many of these have been focused on
dopamine or other agonists of the dopamine receptor
since it is known that this causes renal artery
dilatation. Low dose dopamine has shown no differ-
ence in post-operative (days 1 and 5) creatinine, urea
or creatinine clearance when compared to placebo in a
double-blind randomized-controlled trial.54 In 17
patients who received dopexamine (an agonist at
both the D1 and D2 receptor) compared to 15 who
received only placebo, a reduction in the post-
operative creatinine rise was noted by Welch et al.55
Fenoldopam (a highly selective D1 agonist) reduced
AAA and Renal Failure 7the duration of the fall in creatinine clearance
associated with aortic clamping,56 however, since no
control group was used it is impossible to be sure this
effect was due to fenolodopam.
The calcium channel antagonist nifedipine causes
renal vasodilatation and reduces renal vascular tone,
thereby increasing renal blood flow and glomerular
filtration rate, both of which should be advantageous
in AAA repair. Antonucci et al.57 compared eight
patients receiving nifedipine with eight receiving low
dose dopamine during infra-renal aortic cross-clamp-
ing for AAA repair. In the group, receiving dopamine
there was a reduction in glomerular filtration rate and
creatinine clearance that was not seen in the nifedipine
group. Licker et al.58 examined the effect of enalapril in
patients with normal renal function undergoing
elective AAA repair. Enalapril, by preventing the
conversion of angiotensin I to angiotensin II should
reduce the vasoconstriction in the renal vasculature
caused by activation of the rennin-angiotensin-aldos-
terone system and thereby improve renal function.
Eleven patients received enalapril and nine placebo.
The enalapril group had a similar drop in creatinine
clearance as the placebo group during aortic clamping
but on clamp release those receiving enalapril rapidly
returned to near normal levels of creatinine clearance
(within 2 min of removing the aortic clamp) whereas
the placebo group had not returned to normal by the
end of the sampling period 24 h post-operatively.
Relatively early in the history of aortic surgery the
osmotic diuretic/free radical scavenger mannitol was
proposed as a reno-protective agent. Whilst the ability
of mannitol to induce a diuresis in these patients was
demonstrated its effects on renal function were not
reported.59–61 The most recent clinical trial of mannitol
(and only study since 1963) demonstrated no signifi-
cant difference in serum urea, serum creatinine or
creatinine clearance post-operatively (at 1, 3 and 7
days) between 15 patients who received a mannitol
bolus prior to renal cross-clamping and 13 who did
not.62 Urinary albumin–creatinine and n-acetyl gluco-
saminidase-creatinine ratios were reduced in the
mannitol group suggesting reduced glomerular and
tubular damage in the mannitol group (respectively).
All patients in this study had normal renal function
and were undergoing elective AAA repair. It has been
suggested that mannitol prevents renal damage by
either an osmotic-diuretic effect improving renal blood
flow, preventing casts precipitating in the tubules and
reducing proximal tubular swelling (osmotic effect
only), or it may be due to free radical scavenging of
reactive oxygen species in re-vascularised tissues, thus
preventing secondary renal damage. The only evi-
dence suggesting the first of these effects is that otheranti-oxidants (vitamin-E, vitamin-C, allopurinol, n-
acetyl cysteine and mannitol) given in combination
before AAA repair have no effect on urinary albumin–
creatinine ratio.63 Similarly, to the study above
examining mannitol alone there was no effect on
post-operative serum creatinine. A slight increase in
creatinine clearance in the anti-oxidant group was
seen 2 days post-operatively but this was not evident
immediately after surgery or on discharge home.
All of the above studies demonstrate biochemical
effects of each individual pharmaceutical agent but no
clinical effects are apparent. In addition, since there are
no trials examining clinical outcome in large groups of
patients it is difficult to suggest that any of the above
pharmaceutical therapies should be routinely adopted
at present.Maintenance of Peritoneal Dialysis Peri-operatively
Whilst most surgeons would probably recommend
that patients with end-stage renal failure dialysing via
peritoneal catheters be changed to haemodialysis for
the peri-operative period to avoid the risks of graft
infection and to maintain adequate dialysis there is
some evidence in patients without pre-existing renal
impairment that this may not be necessary. Some
groups have reported placing peritoneal dialysis
catheters at the time of ruptured AAA repair to be
used in the event of post-operative renal failure.64 In 69
patients with catheters placed they were used as the
sole method for post-operative renal support in eight
patients and in combination with haemodialysis in
nine. Whilst there was an increased incidence of
wound infections in these patients only one graft
infection occurred, after a period of 4 years and this
was attributed to complicated diverticular disease.
Three patients developed peritonitis secondary to the
presence of the catheter. Other authors have reported
series of patients with acute renal failure following
ruptured AAA repair treated by peritoneal dialysis
but with high mortality rates (87%).65 Whether this
highmortality was due to peritoneal dialysis or merely
due to the high mortality in this group of patients
cannot be determined.Endovascular Aneurysm Repair in Patients with
Renal Impairment
Patients with renal impairment are usually considered
to be high risk. The possibility of endovascular
aneurysm repair (EVAR) with reduced mortality risk
is, therefore, attractive. Case reports have describedEur J Vasc Endovasc Surg Vol 30, July 2005
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and ruptured AAA who would otherwise have not
been fit for open surgery66 and have described
successful endovascular treatment of renal artery
stenosis, either concurrently or prior to EVAR.67
There is some evidence that EVAR results in
reduced renal injury when compared to open AAA
repair. Urinary albumin–creatinine ratios and N-
acetyl-beta-D-glucosaminidase, both sensitive markers
of renal impairment, are reduced during the immedi-
ate peri-operative period in patients with normal renal
function undergoing EVAR.68,69 Both of these studies
identified that in all patients both of these measure-
ments return to normal values within 2–3 days of
surgery.
Few studies were identified that had examined
EVAR in patients with renal impairment and reported
results in terms of both mortality and deterioration in
renal function vary. One comparative study of 23
patients with renal impairment (creatinine greater
than 176 mmol/l) reportedmortality rates of 10% in the
open group (10 patients) and 0% in the EVAR group
(13 patients).70 In a report of 50 ‘high risk’ patients
undergoing EVAR by Chuter et al.71 13 were con-
sidered to be high risk because of elevated serum
creatinine levels (greater than 133 mmol/l) and none of
these patients died. No details are given of long-term
renal function. Walker et al.72 examined a group with
renal impairment (15 patients, creatinine greater than
130 mmol/l, median 227 mmol/l) including two with
end-stage renal failure. None of those who survived
had any deterioration in renal function, however, the
mortality rate in this group was 26%, with three deaths
partly due to a deterioration in renal function. In their
comparison group of 149 patients with normal renal
function the mortality rate was 1.3% but three patients
in this group had one renal artery inadvertently
covered by the graft itself and all developed impaired
renal function. Carpenter et al.73 described 98 patients,
in whom those with pre-operative renal impairment
had a higher rate of deterioration in renal function
(40%) compared with those with normal pre-operative
renal function (19%) but there was no difference in
mortality between the groups.
One aspect of EVAR which could theoretically be
detrimental to long-term renal function is supra-renal
stent fixation. In series where EVAR has been
performed with supra-renal fixation there does not
appear to be any significant effect on renal function.74–77
Deterioration in renal artery stenosis has been
observed,74 however, these cases can be treated at a
later date by renal artery stenting which can be passed
through the interstices of the aortic stent.75,76 Where
supra- and infra-renal graft fixation has beenEur J Vasc Endovasc Surg Vol 30, July 2005compared directly there appears to be no effect of
supra-renal fixation on renal function or pre-existing
renal artery stenosis unless the actual graft is
inadvertently positioned covering the origin of the
renal arteries.78
The long-term effects of supra-renal fixation has
only been reported in one article examining patients
with normal renal function.79 At 6 and 12 months
follow up patients with suprarenal fixation (32)
showed no significant rise in creatinine when com-
pared to baseline levels. Those with infra-renal fixation
(57) conversely did have a significant rise in serum
creatinine levels at both 6 and 12 months. Between the
two groups there was no significant difference in the
rise in creatinine.
Whilst there may be no effect of supra-renal stent
fixation on measurable renal function there is some
evidence of renal infarction in these patients.77 Kramer
et al.80 identified 16 renal infarctions identified at 12
months following EVAR in 99 patients. Six of these
were in suprarenally fixed stents (69 arteries, 8.7%)
and seven were in infrarenal fixation (124 arteries,
5.6%). Three were due to intentional accessory artery
occlusion. Whether this loss of renal parenchyma has
implications for long-term renal function is unknown
but in patients with pre-existing renal impairment this
may be significant.
There is some evidence that infra-renal fixation may
cause renal damage. Harris et al.81 demonstrated that
the amount of atheroma in the neck of the AAA was
directly proportional to the degree of renal damage
(assessed by the incidence on new renal perfusion
defects on follow-up CT scanning). Another factor to
consider when infra-renally fixing stent-grafts is the
presence of accessory renal arteries. Covering these
with stent-grafts has been shown to be a cause of
segmental renal infarctions but does not appear to
result in a deterioration in renal function.82Summary
The management of patients with AAA and renal
impairment is not straightforward. There is little data
regarding patients with end-stage renal failure and
AAA although these patients appear to have a high
peri-operative mortality rate. In contrast, those with
renal impairment do not have a significantly higher
mortality rate than those with normal renal function,
rather they have a higher risk of complications
associated with surgery and may require more
intensive post-operative organ system support than
normal patients. Many have a transient deterioration
in renal function in the immediate peri-operative
AAA and Renal Failure 9period that will resolve. In the case of patients with
ruptured AAA it is not clear whether pre-operative
renal impairment affects mortality.
In preparing these patients for surgery there may be
the opportunity to treat reversible causes of renal
impairment such as renal artery stenosis, either pre-
operatively or concurrently with AAA repair. There is
little evidence to suggest that any pharmaceutical
therapy given intra-operatively has any significant
effect on long- or short-term renal function or outcome.
Endovascular aneurysm repair may, in the future,
prove to be a useful alternative treatment in this
particular patient group.
There are many unanswered questions regarding
this subset of patients. Unfortunately, the only studies
large enough to contain meaningful data lack detail
and it is unlikely that any one centre has a large
enough contemporaneous case-load in order to pro-
vide this. Further investigation into the benefits of
endovascular repair in these patients is required and it
may be that reports from the EVAR one and two trials
or multicentre registries such as Eurostar may contain
this data.
In terms of individual patients it is difficult to
recommend a management strategy that covers all
eventualities. Adequate pre-operative hydration
should be ensured for all patients prior to surgery
and any nephrotoxic drugs should be withdrawn.
There is no evidence to suggest that patients with renal
impairment are at any increased risk of rupture than
patients with normal renal function.83 We would
suggest that patients are not turned down for surgery
on the basis of impaired renal function, rather, they
should be appropriately counselled prior to surgery
and provided they are fully aware of the risks of
surgery then it should proceed.References
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